Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Cycle | 3 | 2018 | 616 | 1.040 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 22 | 0.740 |
Why?
|
| Karyopherins | 2 | 2018 | 36 | 0.740 |
Why?
|
| Cytosol | 1 | 2021 | 161 | 0.720 |
Why?
|
| Hydrazines | 3 | 2018 | 29 | 0.690 |
Why?
|
| Triazoles | 3 | 2018 | 139 | 0.640 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2018 | 389 | 0.600 |
Why?
|
| Cell Tracking | 1 | 2015 | 16 | 0.500 |
Why?
|
| Neurons | 3 | 2021 | 1965 | 0.460 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 719 | 0.450 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 2055 | 0.410 |
Why?
|
| Apoptosis | 2 | 2019 | 1790 | 0.400 |
Why?
|
| Cell Death | 4 | 2021 | 240 | 0.370 |
Why?
|
| Antineoplastic Agents | 3 | 2018 | 1674 | 0.360 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2018 | 54 | 0.280 |
Why?
|
| Cell Line, Tumor | 5 | 2020 | 3342 | 0.240 |
Why?
|
| Cell Survival | 2 | 2018 | 806 | 0.230 |
Why?
|
| Ribonucleoproteins | 1 | 2024 | 62 | 0.230 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2024 | 64 | 0.230 |
Why?
|
| Primary Cell Culture | 2 | 2021 | 101 | 0.220 |
Why?
|
| Oxidative Stress | 3 | 2024 | 813 | 0.190 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 2021 | 1 | 0.190 |
Why?
|
| Cathepsin D | 1 | 2020 | 16 | 0.170 |
Why?
|
| Benzoxazoles | 1 | 2020 | 11 | 0.170 |
Why?
|
| Neuroprotection | 1 | 2020 | 26 | 0.170 |
Why?
|
| Azepines | 1 | 2020 | 61 | 0.170 |
Why?
|
| Enzyme Activation | 1 | 2021 | 624 | 0.170 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 157 | 0.160 |
Why?
|
| Hypoxia | 1 | 2021 | 246 | 0.160 |
Why?
|
| Sulfotransferases | 1 | 2019 | 27 | 0.160 |
Why?
|
| Translocation, Genetic | 1 | 2021 | 356 | 0.160 |
Why?
|
| Lysosomes | 1 | 2020 | 236 | 0.150 |
Why?
|
| G1 Phase | 1 | 2018 | 67 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 79 | 0.150 |
Why?
|
| Imidazoles | 1 | 2018 | 194 | 0.140 |
Why?
|
| Pyrimidines | 1 | 2020 | 374 | 0.140 |
Why?
|
| Autophagy | 1 | 2020 | 395 | 0.140 |
Why?
|
| Piperazines | 1 | 2018 | 233 | 0.130 |
Why?
|
| Glucose | 1 | 2021 | 885 | 0.130 |
Why?
|
| Cell Lineage | 1 | 2018 | 348 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 532 | 0.130 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 117 | 0.120 |
Why?
|
| Cells, Cultured | 1 | 2021 | 3052 | 0.120 |
Why?
|
| Neoplasms | 2 | 2020 | 2801 | 0.120 |
Why?
|
| Mitochondria | 1 | 2019 | 689 | 0.110 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 261 | 0.110 |
Why?
|
| DNA Damage | 1 | 2017 | 515 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1239 | 0.110 |
Why?
|
| Single-Cell Analysis | 1 | 2015 | 274 | 0.100 |
Why?
|
| Stroke | 1 | 2020 | 974 | 0.100 |
Why?
|
| Mice | 4 | 2021 | 17728 | 0.090 |
Why?
|
| Pregnancy | 1 | 2021 | 7167 | 0.080 |
Why?
|
| Animals | 4 | 2021 | 34145 | 0.070 |
Why?
|
| Protein Binding | 2 | 2024 | 1749 | 0.070 |
Why?
|
| Phenotype | 1 | 2015 | 4255 | 0.060 |
Why?
|
| Endoribonucleases | 1 | 2024 | 82 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2024 | 291 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2024 | 328 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2024 | 809 | 0.050 |
Why?
|
| Humans | 6 | 2024 | 124404 | 0.050 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2020 | 28 | 0.040 |
Why?
|
| Aurora Kinase A | 1 | 2020 | 39 | 0.040 |
Why?
|
| Maximum Tolerated Dose | 1 | 2020 | 158 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2019 | 50 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2020 | 164 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2019 | 892 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2020 | 258 | 0.040 |
Why?
|
| Female | 2 | 2021 | 66305 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 887 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 492 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 455 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 722 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 1393 | 0.030 |
Why?
|
| DNA Replication | 1 | 2017 | 350 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 1688 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 3753 | 0.020 |
Why?
|
| Brain | 1 | 2020 | 3003 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 19479 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 26460 | 0.010 |
Why?
|
| Male | 1 | 2020 | 61028 | 0.010 |
Why?
|